Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids

References

• Gibbons PW, Kim J, Cash RE, et al. Influence of ICU surge and capacity on COVID mortality across U.S. states and regions during the COVID-19 pandemic. J Intensive Care Med. 2023: 08850666231157338. doi:10.1177/08850666231157338
   Web of Science ®Google Scholar
• Saito, A, Irie T, Suzuki R, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602:300–306. doi:10.1038/s41586-021-04266-9
   PubMed Web of Science ®Google Scholar
• Shuai, H, Chan JF-W, Hu B, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603:693–699. doi:10.1038/s41586-022-04442-5
   PubMed Web of Science ®Google Scholar
• Munster, VJ, Flagg M, Singh M, et al. Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques. Sci Adv. 2021;7:eabj3627. doi:10.1126/sciadv.abj3627
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Singh M, Saturday TA, et al. SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta. Sci Adv. 2022;8:eade1860. doi:10.1126/sciadv.ade1860
   PubMed Web of Science ®Google Scholar
• Rissmann, M, Noack D, van Riel D, et al. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters. Emerg Microbes Infect. 2022;11:1778–1786. doi:10.1080/22221751.2022.2095932
   PubMed Web of Science ®Google Scholar
• McMahan, K, Giffin V, Tostanoski LH, et al. Reduced pathogenicity of the SARS-CoV-2 Omicron variant in hamsters. Med. 2022;3:262–268.e4. doi:10.1016/j.medj.2022.03.004
   PubMedGoogle Scholar
• Halfmann, PJ, Iida S, Iwatsuki-Horimoto K, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 2022;603:687–692. doi:10.1038/s41586-022-04441-6
   PubMed Web of Science ®Google Scholar
• Armando, F, Beythien G, Kaiser FK, et al. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Nat Commun. 2022;13:3519. doi:10.1038/s41467-022-31200-y
   PubMed Web of Science ®Google Scholar
• Yuan, S, Ye Z-W, Liang R, et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science. 2022;377:428–433. doi:10.1126/science.abn8939
   PubMed Web of Science ®Google Scholar
• Speranza, E, Purushotham JN, Port JR, et al. Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques. Life Sci Alliance. 2022;5:e202101314. doi:10.26508/lsa.202101314
   PubMed Web of Science ®Google Scholar
• Munster, VJ, Feldmann F, Williamson BN, et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020;585:268–272. doi:10.1038/s41586-020-2324-7
   PubMed Web of Science ®Google Scholar
• Wei, Y, Aris P, Farookhi H, et al. Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective. Sci Rep-UK. 2021;11:1702. doi:10.1038/s41598-020-80573-x
   PubMed Web of Science ®Google Scholar
• Piplani, S, Singh PK, Winkler DA, et al. In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin. Sci Rep-UK. 2021;11:13063. doi:10.1038/s41598-021-92388-5
   PubMed Web of Science ®Google Scholar
• Kling, MA. A review of respiratory system anatomy, physiology, and disease in the mouse, rat, hamster, and gerbil. Vet Clin North Am Exot Animal Pract. 2011;14:287–337. doi:10.1016/j.cvex.2011.03.007
   PubMedGoogle Scholar
• Melin, AD, Janiak MC, Marrone F, et al. Comparative ACE2 variation and primate COVID-19 risk. Commun Biology. 2020;3:641. doi:10.1038/s42003-020-01370-w
   PubMed Web of Science ®Google Scholar
• Minkoff, JM, tenOever B. Innate immune evasion strategies of SARS-CoV-2. Nat Rev Microbiol. 2023: 1–17. doi:10.1038/s41579-022-00839-1
   Web of Science ®Google Scholar
• Fish, I, Boissinot S. Contrasted patterns of variation and evolutionary convergence at the antiviral OAS1 gene in old world primates. Immunogenetics. 2015;67:487–499. doi:10.1007/s00251-015-0855-0
   PubMed Web of Science ®Google Scholar
• de Matos, AL, McFadden G, Esteves PJ. Positive evolutionary selection on the RIG-I-like receptor genes in mammals. PLoS One. 2013;8:e81864. doi:10.1371/journal.pone.0081864
   PubMed Web of Science ®Google Scholar
• Barkauskas CE, Cronce MJ, Rackley CR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123:3025–3036. doi:10.1172/jci68782
   PubMed Web of Science ®Google Scholar
• Sachs, N, Papaspyropoulos A, Ommen DDZ, et al. Long-term expanding human airway organoids for disease modeling. Embo J. 2019;38; doi:10.15252/embj.2018100300
   PubMed Web of Science ®Google Scholar
• Katsura, H, Sontake V, Tata A, et al. Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction. Cell Stem Cell. 2020;27:890–904.e8. doi:10.1016/j.stem.2020.10.005
   PubMed Web of Science ®Google Scholar
• Youk, J, Kim T, Evans KV, et al. Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2. Cell Stem Cell. 2020;27:905.e10–919.e10. doi:10.1016/j.stem.2020.10.004
   Web of Science ®Google Scholar
• Salahudeen, AA, Choi SS, Rustagi A, et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature. 2020;588:670–675. doi:10.1038/s41586-020-3014-1
   PubMed Web of Science ®Google Scholar
• Tindle, C, Fuller M, Fonseca A, et al. Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19. Elife. 2021;10:e66417. doi:10.7554/elife.66417
   PubMed Web of Science ®Google Scholar
• Lamers, MM, Vaart J, Knoops K, et al. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. Embo J. 2021;40:e105912. doi:10.15252/embj.2020105912
   PubMed Web of Science ®Google Scholar
• Mulay, A, Konda B, Garcia G, et al. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell Rep. 2021;35:109055. doi:10.1016/j.celrep.2021.109055
   PubMed Web of Science ®Google Scholar
• Kim, T, Min KI, Yang J-S, et al. Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells. iScience. 2022;25:105571. doi:10.1016/j.isci.2022.105571
   PubMed Web of Science ®Google Scholar
• Abdullah, F, Myers J, Basu D, et al. Decreased severity of disease during the first global Omicron variant COVID-19 outbreak in a large hospital in Tshwane, South Africa. Int J Infect Dis. 2022;116:38–42. doi:10.1016/j.ijid.2021.12.357
   PubMed Web of Science ®Google Scholar
• Lauring, AS, Tenforde MW, Chappell JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from Omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. Br Med J. 2022;376:e069761. doi:10.1136/bmj-2021-069761
   PubMedGoogle Scholar
• Iuliano, AD, Brunkard JM, Boehmer TK, et al. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods — United States, December 2020–January 2022. Morbidity Mortal Wkly Rep. 2022;71:146–152. doi:10.15585/mmwr.mm7104e4
   PubMed Web of Science ®Google Scholar
• Sievers, C, Zacher B, Ullrich A, et al. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022. Eurosurveillance. 2022;27:2200396. doi:10.2807/1560-7917.es.2022.27.22.2200396
   Web of Science ®Google Scholar
• Wolter, N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–446. doi:10.1016/s0140-6736(22)00017-4
   PubMed Web of Science ®Google Scholar
• Zhang, H, Zhou P, Wei Y, et al. Histopathologic changes and SARS–CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Intern Med. 2020;172; doi:10.7326/m20-0533
   Web of Science ®Google Scholar
• Hou, YJ, Okuda K, Edwards CE, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182:429.e14–446.e14. doi:10.1016/j.cell.2020.05.042
   Web of Science ®Google Scholar
• Speranza, E, Williamson BN, Feldmann F, et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med. 2021: eabe8146. doi:10.1126/scitranslmed.abe8146
   PubMed Web of Science ®Google Scholar
• Li, S, Jiang L, Li X, et al. Clinical and pathological investigation of severe COVID-19 patients. JCI Insight. 2020;5; doi:10.1172/jci.insight.138070
   Web of Science ®Google Scholar
• Travaglini, KJ, Nabhan AN, Penland L, et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 2020;587:619–625. doi:10.1038/s41586-020-2922-4
   PubMed Web of Science ®Google Scholar
• Murthy, PKL, Sontake V, Tata A, et al. Human distal lung maps and lineage hierarchies reveal a bipotent progenitor. Nature. 2022;604:111–119. doi:10.1038/s41586-022-04541-3
   PubMed Web of Science ®Google Scholar
• Mostafavi, S, Yoshida H, Moodley D, et al. Parsing the interferon transcriptional network and its disease associations. Cell. 2016;164:564–578. doi:10.1016/j.cell.2015.12.032
   PubMed Web of Science ®Google Scholar
• June 2021 Risk Assessment for SARS-CoV-2 Variant: Delta (VOC-21APR-02, B.1.617.2). (2021). Public Health England. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/991135/3_June_2021_Risk_assessment_for_SARS-CoV-2_variant_DELTA.pdf.
   Google Scholar
• Sheikh, A, McMenamin J, Taylor B, et al. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397:2461–2462. doi:10.1016/s0140-6736(21)01358-1
   PubMed Web of Science ®Google Scholar
• Twohig, KA, Nyberg T, Zaidi A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022;22:35–42. doi:10.1016/s1473-3099(21)00475-8
   PubMed Web of Science ®Google Scholar
• Jassat, W, Mudara C, Ozougwu L, et al. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Global Heal. 2021;9:e1216–e1225. doi:10.1016/s2214-109x(21)00289-8
   PubMed Web of Science ®Google Scholar
• Duan, F, Guo L, Yang L, et al. Modeling COVID-19 with human pluripotent stem cell-derived cells reveals synergistic effects of anti-inflammatory macrophages with ACE2 inhibition against SARS-CoV-2. Res Square. 2020; doi:10.21203/rs.3.rs-62758/v2
   Google Scholar
• Gough, DJ, Messina NL, Clarke CJP, et al. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity. 2012;36:166–174. doi:10.1016/j.immuni.2012.01.011
   PubMed Web of Science ®Google Scholar
• Bradley, KC, Finsterbusch K, Schnepf D, et al. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep. 2019;28:245.e4–256.e4. doi:10.1016/j.celrep.2019.05.105
   Web of Science ®Google Scholar
• Meliopoulos, VA, de Velde L-AV, de Velde NCV, et al. An epithelial integrin regulates the amplitude of protective lung interferon responses against multiple respiratory pathogens. Plos Pathog. 2016;12:e1005804. doi:10.1371/journal.ppat.1005804
   PubMed Web of Science ®Google Scholar
• Broadbent, L, Bamford CGG, Campos GL, et al. An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells. PLoS One. 2022;17:e0266412. doi:10.1371/journal.pone.0266412
   PubMed Web of Science ®Google Scholar
• Thorne, LG, Bouhaddou M, Reuschl A-K, et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2021: 1–12. doi:10.1038/s41586-021-04352-y
   Web of Science ®Google Scholar
• Tandel, D, Sah V, Singh NK, et al. SARS-CoV-2 variant delta potently suppresses innate immune response and evades interferon-activated antiviral responses in human colon epithelial cells. Microbiol Spectr. 2022;10:e01604–e01622. doi:10.1128/spectrum.01604-22
   PubMed Web of Science ®Google Scholar
• Zhang, Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi:10.1126/science.abd4570
   PubMed Web of Science ®Google Scholar
• Pairo-Castineira, E, Rawlik K, Bretherick AD, et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023: 1–15. doi:10.1038/s41586-023-06034-3
   Google Scholar
• Zhou, S, Butler-Laporte G, Nakanishi T, et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021;27:659–667. doi:10.1038/s41591-021-01281-1
   PubMed Web of Science ®Google Scholar
• Wickenhagen, A, Sugrue E, Lytras S, et al. A prenylated dsRNA sensor protects against severe COVID-19. Science. 2021;374:eabj3624. doi:10.1126/science.abj3624
   PubMed Web of Science ®Google Scholar
• Rihn, SJ, Merits A, Bakshi S, et al. A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biol. 2021;19:e3001091. doi:10.1371/journal.pbio.3001091
   PubMed Web of Science ®Google Scholar
• Corman, VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:2000045. doi:10.2807/1560-7917.es.2020.25.3.2000045
   Web of Science ®Google Scholar
• Wölfel, R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. doi:10.1038/s41586-020-2196-x
   PubMed Web of Science ®Google Scholar
• Haddock, E, Feldmann F, Shupert WL, et al. Inactivation of SARS-CoV-2 laboratory specimens. Am J Trop Med Hyg. 2021;104:2195–2198. doi:10.4269/ajtmh.21-0229
   PubMed Web of Science ®Google Scholar
• Gottschalk, PG, Dunn JR. The five-parameter logistic: a characterization and comparison with the four-parameter logistic. Anal Biochem. 2005;343:54–65. doi:10.1016/j.ab.2005.04.035
   PubMed Web of Science ®Google Scholar